Plasmin Regulates the Activation of Cell-associated Latent TGF-β1 Secreted by Rat Alveolar Macrophages after in Vivo Bleomycin Injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 15, Issue 2, 1996, Pages 252-259

  Khalil, Nasreen ^a   Corne, Steven ^b   Whitman, Carol ^b   Yacyshyn, Harold ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPLASMIN; BLEOMYCIN; PLASMIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CELL CULTURE; CELL LINE; CHEMICALLY INDUCED DISORDER; CULTURE MEDIUM; DRUG EFFECT; EPITHELIUM CELL; FEMALE; IMMUNOLOGY; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE ACTIVATION; MINK; PATHOLOGY; PHYSIOLOGY; PNEUMONIA; PROTEIN PROCESSING; RAT; SECRETION; SPRAGUE DAWLEY RAT; TIME; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTIPLASMIN; BIOLOGICAL TRANSPORT; BLEOMYCIN; CELL LINE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; FEMALE; LYMPHOCYTE ACTIVATION; MACROPHAGES, ALVEOLAR; MINK; PLASMIN; PNEUMONIA; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030211121     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.15.2.8703482     Document Type: Article

References (35)

1. 1 regulation of extracellular matrix. Kidney Int. 41:557-559.
2. Roberts, A. B., and M. B. Sporn. 1992. The transforming growth factor-betas. In Peptide Growth Factors and Their Receptors: Handbook of Experimental Pharmacology, Vol. 95. M. B. Sporn and A. B. Roberts, editors. Springer-Verlag, New York. 419-472.
3. McCartney-Francis, N. L., and S. M. Wahl. 1994. Transforming growth factor β: a matter of life and death. J. Leukoc. Biol. 55:401-409.
4. Khalil, N., O. Bereznay, M. B. Sporn, and A. H. Greenberg. 1989. Macrophage production of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:727-737.
5. Khalil, N., C. Whitman, L. Zuo, D. Danielpour, and A. H. Greenberg. 1993. Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J. Clin. Invest. 92:1812-1818.
6. Kelly, J., E. J. Kovacs, K. Nicholson, and J. P. Fabisiak. 1991. Transforming growth factor β production by lung macrophages and fibroblasts. Chest 99: S85-S86.
7. 1 activity: latency vs. activation. Progr. Growth Factor Res. 4:321-335.
8. Miyazano, K., P. T. Dijke, H. Schijo, and C. H. Heldin. 1994. Receptors for transforming growth factor-β. Adv. Immunol. 55:181-220.
9. Schultz-Cherry, S., and J. E. Murphy-Ullrich. 1993. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122:923-932.
10. Holt, P. G. 1979. Alveolar macrophages. I. A simple technique for the preparation of high numbers of viable alveolar macrophages from small laboratory animals. J. Immunol. Methods 27:189-198.
11. 2 secreted by cells in culture. J. Cell. Physiol. 138:79-86.
12. Andreasen, P. A., B. Georg, L. R. Lund, A. Riccio, and S. M. Stacey. 1990. Plasminogen activator inhibitors: hormonally regulated serpins. Mol. Cell. Endocrinol. 68:1-19.
13. Kwaan, H. C. 1992. The plasminogen-plasmin system in malignancy. Cancer Metastasis Review 11:291-311.
14. Lyons, R. M., L. E. Gentry, A. F. Purchio, and H. L. Moses. 1990. Mechanism of activation of latent recombinant transforming growth factor β by plasmin. J. Cell Biol. 110:1361-1367.
15. Auger, M. J. 1989. Mononuclear phagocytes. BMJ 298:546-548.
16. Cormack, D. T., B. Porras-Reyes, and T. A. Mustoe. 1990. Current concepts in wound healing: growth factor and macrophage interaction. J. Trauma 30:S129-S133.
17. Rappolee, D. A., and Z. Werb. 1992. Macrophage-derived growth factors. Curr. Top. Microbiol. Immunol. 181:87-140.
18. McCartney-Francis, N., D. Mizel, H. Wong, L. Wahl, and S. Wahl. 1990. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factor 4:27-35.
19. Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84:5788-5792.
20. Chandler, D. B., D. M. Hyde, and S. N. Giri. 1983. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am. J. Pathol. 112:170-177.
21. Sato, Y., and D. B. Rifkin. 1989. Inhibition of endothelial cell movement by pericytes and smooth muscle cell: activation of a latent transforming growth factor-β-like molecule by plasmin during co-culture. J. Cell Biol. 109:309.
22. Plow, E. F., L Herren, A. Redlitz, L. A. Miles, and J. L. Hoover-Plow. 1995. The cell biology of the plasminogen system. FASEB J. 9:939-945.
23. Pöllänen, J., R. W. Stevens, and A. Vaheri. 1991. Directed plasminogen activation at the surface of normal and malignant cells. Adv. Can. Res. 57:273-328.
24. Ellis, N., N. Behrendt, and K. Dano. 1991. Plasminogen: activation by receptor-bound urokinase: a kinetic study with both cell associated and isolated receptor. J. Biol. Chem. 266:12752-12758.
25. Kirchheimer, J. C., and H. G. Remold. 1989. Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to activation by plasminogen activator inhibitors. Blood 74: 1396-1402.
26. Schultze, A. E., J. G. Wagner, and R. A. Roth. 1991. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrole. Toxicol. Appl. Pharmacol. 109:421-431.
27. Olman, M. A., N. Mackman, C. L. Gladson, K. M. Moser, and D. J. Loskutoff. 1995. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J. Clin. Invest. 96: 1621-1630.
28. Dennis, P. A., and D. B. Rifkin. 1991. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor. Proc. Natl. Acad. Sci. USA 88:580-584.
29. Kojima, S., K. Nara, and D. B. Rifkin. 1993. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J. Cell Biol. 121:439-448.
30. Phan, S. H., and J. C. Fantose. 1984. Inhibition of bleomycin induced pulmonary fibrosis by lipopolysaccharide. Lab Invest. 50:587-591.
31. Redl, H., S. Bahrami, G. Schlag, and D. L. Traber. 1993. Clinical detection of LPS and animal models of endotoxemia. Immunobiology 187:330-345.
32. Tryggvason, K., M. Höyhtyä, and T. Salo. 1987. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta 907: 191-217.
33. Eitzman, D. T., R. D. McCoy, X. Zheng, W. P. Fay, T. Shen, and D. Ginsburg. 1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen inhibitor-1 gene. J. Clin. Invest. 97:232-237.
34. Strieter, R. M., J. P. Lynch, M. A. Basha, T. J. Standford, K. Kasahara, and S. L. Kunkel. 1990. Host responses in mediating sepsis and adult respiratory distress syndrome. Semin. Respir. Infect. 5:233-247.
35. Giri, S. N., D. M. Hyde, and M. A. Hollinger. 1993. Effects of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice. Thorax 48:959-966.